Radiation sensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls: Colony formation ability during continuous low-dose-rate gamma irradiation

Radiation Research

Volumn 169, Issue 5, 2008, Pages 483-494

  Wilson, Paul F ^a,b   Nagasawa, Hatsumi ^a   Warner, Christy L ^a   Fitzek, Markus M ^c   Little, John B ^d   Bedford, Joel S ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL KILLING; CELL SURVIVAL; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DNA REPAIR; FEMALE; FIBROBLAST; GAMMA RADIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RETINOBLASTOMA;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLASTS; HEALTH; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RADIATION TOLERANCE; RETINOBLASTOMA;

EID: 43449108282     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1333.1     Document Type: Article

References (95)

1. M. M. Fitzek, W. K. Dahlberg, H. Nagasawa, S. Mukai, J. E. Munzenrider and J. B. Little, Unexpected sensitivity to radiation of fibroblasts from unaffected parents of children with hereditary retinoblastoma. Int. J. Cancer 99, 764-768 (2002).
2. E. Y. Chuang, X. Chen, M-H. Tsai, H. Yan, C-Y. Li, J. B. Mitchell, H. Nagasawa, P. F. Wilson, Y. Peng and J. B. Little, Abnormal gene expression profiles in unaffected parents of patients with hereditary type retinoblastoma. Cancer Res. 66, 3428-3433 (2006).
3. H. H. Chun and R. A. Gatti, Ataxia-telangiectasia, an evolving phenotype. DNA Repair 3, 1187-1196 (2004).
4. A. M. R. Taylor, A. Groom and P. J. Byrd. Ataxia-telangiectasia-like disorder (ATLD) - its clinical presentation and molecular basis. DNA Repair 3, 1219-1225 (2004).
5. M. Digweed and K. Sperling, Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair 3, 1207-1217 (2004).
6. 1 phase. Radiat. Res. 118, 559-567 (1989).
7. A. R. Collins, Mutant rodent cell lines sensitive to ultraviolet light, ionizing radiation and cross-linking agents: a comprehensive survey of genetic and biochemical characteristics. Mutat. Res. DNA Repair 293, 99-118 (1993).
8. J. M. Hinz, N. A. Yamada, E. P. Salazar, R. S. Tebbs and L. H. Thompson, Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA Repair 4, 782-792 (2005).
9. S. Ban, R. B. Setlow, M. A. Bender, H. Ezaki, T. Hiraoka, M. Yamane, M. Nishiki, K. Dohi, A. A. Awa and G. W. Beebe, Radiosensitivity of skin fibroblasts from atomic bomb survivors with and without breast cancer. Cancer Res. 50, 4050-4055 (1990).
10. M. A. Hannan, Y. Siddiqui, A. Rostom, M. N. Al-Ahdal, M. A. Chaudhary and M. Kunhi, Evidence of DNA repair/processing defects in cultured skin fibroblasts from breast cancer patients. Cancer Res. 61, 3627-3631 (2001).
11. D. Scott, Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet. Genome Res. 104, 365-370 (2004).
12. S. B. Bigelow, J. M. Rary and M. A. Bender, G2 chromosomal radiosensitivity in Fanconi's anemia. Mutat. Res. 63, 189-199 (1979).
13. R. Kalb, M. Duerr, M. Wagner, S. Herterich, M. Gross, M. Digweed, H. Joenje, H. Hoehn and D. Schindler, Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat. Res. 161, 318-325 (2004).
14. R. R. Weichselbaum, J. Nove and J. B. Little, X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res. 40, 920-925 (1980).
15. H. Nagasawa and J. B. Little, Comparison of kinetics of X-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts. Mutat. Res. 109, 297-308 (1983).
16. J. G. Heras and R. Coco, X-radiation-induced chromosome breakage in retinoblastoma lymphocytes. Mutat. Res. 178, 225-233 (1987).
17. J. V. Pledger, A. W. Craft, K. Bartlett and D. R. Long, X-ray sensitivity of fibroblasts from patients with hereditary retinoblastoma and their families. Br. J. Cancer 55, 617-621 (1987).
18. J. B. Little, W. W. Nichols, P. Troilo, H. Nagasawa and L. C. Strong, Radiation sensitivity of cell strains from families with genetic disorders predisposing to radiation-induced cancer. Cancer Res. 49, 4705-4714 (1989).
19. J. B. Little and J. Nove, Sensitivity of human diploid fibroblast cell strains from various genetics disorders to acute and protracted radiation exposure. Radiat. Res. 123, 87-92 (1990).
20. H. Nagasawa, J. B. Little, N. M. Tsang, E. Saunders, J. Tesmer and G. F. Strniste, Effect of dose rate on the survival of irradiated skin fibroblasts. Radiat. Res. 132, 375-379 (1992).
21. 2 chromatin radiosensitivity in predisposition to cancer. Int. J. Radiat. Biol. 55, 963-981 (1989).
22. 2 phase X-irradiation of cells from retinoblastoma patients. Cancer Genet. Cytogenet. 88, 43-48 (1996).
23. F. B. Geara, L. J. Peters, K. K. Ang, J. L. Wike, S. S. Sivon, R. Guttenberger, D. L. Callender, E. P. Malaise and W. A. Brock, Intrinsic radiosensitivity of normal fibroblasts and lymphocytes after high and low dose-rate irradiation. Cancer Res. 52, 6348-6352 (1992).
24. C. F. Arlett and S. A. Harcourt, Survey of radiosensitivity in a variety of human cell strains. Cancer Res. 40, 926-932 (1980).
25. 2-phase chromosomal aberrations and cell cycle delay. Cancer Res. 48, 4535-4538 (1988).
26. P. J. Deschavanne and B. Fertil, A review of human cell radiosensitivity in vitro. Int. J. Radiat. Oncol. Biol. Phys. 34, 251-266 (1996).
27. E. Dikomey, K. Borgmann, I. Brammer and U. Kasten-Pisula, Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblasts. Toxicology 198, 125-135 (2003).
28. H. W. Mohrenweiser, D. M. Wilson, III and I. M. Jones, Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat. Res. 526, 93-125 (2003).
29. T. Xi, I. M. Jones and H. W. Mohrenweiser, Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83, 970-979 (2004).
30. M. Fernet and J. Hall, Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair 3, 1237-1243 (2004).
31. R. C. Millikan, J. S. Player, A. R. de Cotret, C-K. Tse and T. Keku, Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 14, 2326-2334 (2005).
32. U. Kasten-Pisula, H. Tastan and E. Dikomey, Huge differences in cellular radiosensitivity due to only very small variations in doublestrand break repair capacity. Int. J. Radiat. Biol. 81, 409-419 (2005).
33. C. N. Andreassen, J. Alsner and J. Overgaard, Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look or it? Radiother. Oncol. 64, 131-140 (2002).
34. N. G. Burnet, R. Wurm and J. H. Peacock, Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int. J. Radiat. Biol. 70, 289-300 (1996).
35. F. Vogel, Genetics of retinoblastoma. Hum. Genet. 52, 1-54 (1979).
36. C. Eng, F. P. Li, D. H. Abramson, R. M. Ellsworth, F. L. Wong, M. B. Goldman, J. Seddon, N. Tarbell and J. D. Boice, Jr., Mortality from second tumors among long-term survivors of retinoblastoma. J. Natl. Cancer Inst. 85, 1121-1128 (1993).
37. F. L. Wong, J. D. Boice, Jr., D. H. Abramson, R. E. Tarone, R. A. Kleinerman, M. Stovall, M. B. Goldman, J. M. Seddon, N. Tarbell and F. P. Li, Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. J. Am. Med. Assoc. 278, 1262-1267 (1997).
38. R. A. Kleinerman, M. A. Tucker, R. E. Tarone, D. H. Abramson, J. M. Seddon, M. Stovall, F. P. Li and J. F. Fraumeni, Jr., Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J. Clin. Oncol. 23, 2272-2279 (2005).
39. S. H. Lefèvre, N. Vogt, A-M. Dutrillaux, L. Chauveinc, D. Stoppa-Lyonnet, F. Doz, L. Desjardins, B. Dutrillaux, S. Chevillard and B. Malfoy, Genome instability in secondary tumors developing after radiotherapy of bilateral retinoblastoma. Oncogene 20, 8092-8099 (2001).
40. J. E. van der Wal, M. A. J. A. Hermsen, H. J. P. Gille, N. Y. N. Schouten-van Meeteren, A. C. Moll, S. M. Imhof, G. A. Meijer, J. P. A. Baak and P. van der Valk, Comparative genomic hybridization divides retinoblastomas into a high and a low-level chromosomal instability group. J. Clin. Pathol. 56, 26-30 (2003).
41. P. S. Amare Kadam, P. Ghule, J. Jose, M. Bamne, P. Kurkure, S. Banavali, R. Sarin and S. Advani, Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma. Cancer Genet. Cytogenet. 150, 33-43 (2004).
42. L. Zheng and W-H. Lee, Retinoblastoma tumor suppressor and genome stability. Adv. Cancer Res. 85, 13-50 (2002).
43. L. Zheng, A. Flesken-Nikitin, P-L. Chen and W-H. Lee, Deficiency of retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res. 62, 2498-2502 (2002).
44. E. Hernando, Z. Nahlé, G. Juan, E. Diaz-Rodriguez, M. Alaminos, M. Hemann, L. Michel, V. Mittal, W. Gerald and C. Cordon-Cardo, Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797-802 (2004).
45. C. Stevens and N. B. La Thangue, The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair 3, 1071-1079 (2004).
46. C. Genovese, D. Trani, M. Caputi and P. P. Claudio, Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene 25, 5201-5209 (2006).
47. M. A. Stackhouse and J. S. Bedford, An ionizing radiation-sensitive mutant of CHO cells: irs-20. I. Isolation and initial characterization. Radiat. Res. 136, 241-249 (1993).
48. M. A. Stackhouse and J. S. Bedford, An ionizing radiation-sensitive mutant of CHO cells: irs-20. II. Dose-rate effects and cellular recovery processes. Radiat. Res. 136, 250-254 (1993).
49. J. Y-D. Lin, M. C. Mühlmann-Diaz, M. A. Stackhouse, J. E. Robinson, G. E. Taccioli, D. J. Chen and J. S. Bedford, An ionizing radiation-sensitive mutant CHO mutant cell line: irs-20. IV. Genetic complementation, V(D)J recombination, and the scid phenotype. Radiat. Res. 147, 166-171 (1997).
50. A. Priestly, H. J. Beamish, D. Gell, A. G. Amatucci, M. C. Mühlmann-Diaz, B. K. Singleton, G. C. M. Smith, T. Blunt, L. C. Schalkwyk and G. E. Taccioli, Molecular and biochemical characterization of DNA-dependent protein kinase-defective rodent mutant irs-20. Nucleic Acids Res. 26, 1965-1973 (1998).
51. J. S. Bedford and J. B. Mitchell, Dose-rate effects in synchronous mammalian cells in culture. Radiat. Res. 54, 316-327 (1973).
52. J. B. Mitchell, J. S. Bedford and S. M. Bailey, Dose-rate effects in mammalian cells in culture. III. Comparison of cell killing and cell proliferation during continuous irradiation for six different cell lines. Radiat. Res. 79, 537-551 (1979).
53. J. B. Mitchell, J. S. Bedford and S. M. Bailey, Dose-rate effects on the cell cycle and survival of S3 HeLa and V79 cells. Radiat. Res. 79, 520-536 (1979).
54. J. Thacker and A. Stretch, Recovery from lethal and mutagenic damage during postirradiation holding and low dose-rate irradiations of cultured hamster cells. Radiat. Res. 96, 380-392 (1983).
55. J. Thacker and R. E. Wilkinson, The genetic basis of cellular recovery from radiation damage: response of the radiosensitive irs lines to low-dose-rate irradiation. Radiat. Res. 144, 294-300 (1995).
56. R. J. Amdur and J. S. Bedford, Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line. Int. J. Radiat. Oncol. Biol. Phys. 30, 83-90 (1994).
57. L. A. Jones, D. Scott, R. Cowan and S. A. Roberts, Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol. 67, 519-528 (1995).
58. D. C. Lloyd and A. A. Edwards, Chromosome aberrations in human lymphocytes: effect of radiation quality, dose, and dose rate. In Radiation-Induced Chromosome Damage in Man (T. Ishihara and M. S. Sasaki, Eds.), pp. 23-49. Alan R. Liss, New York, 1983.
59. 60Co gamma rays on human tumor cells in vitro. Radiat. Res. 158, 311-318 (2002).
60. M. N. Cornforth, S. M. Bailey and E. H. Goodwin, Dose responses for chromosome aberrations produced in noncycling primary human fibroblasts by alpha particles, and by gamma rays delivered at sublimiting low dose rates. Radiat. Res. 158, 43-53 (2002).
61. B. D. Loucas, R. Eberle, S. M. Bailey and M. N. Cornforth, Influence of dose rate on the induction of simple and complex chromosome exchanges by gamma rays. Radiat. Res. 162, 339-349 (2004).
62. H. Nakamura, H. Fukami, Y. Hayashi, A. Tachibana, S. Nakatsugawa, M. Hamaguchi and K. Ishizaki, Cytotoxic and mutagenic effects of chronic low dose-rate irradiation on TERT-immortalized human cells. Radiat. Res. 163, 283-288 (2005).
63. 0 lymphocytes exposed in vitro to gamma radiation. Radiat. Res. 165, 43-50 (2006).
64. T. A. Kato, H. Nagasawa, M. M. Weil, J. B. Little and J. S. Bedford, Levels of gamma-H2AX foci after low-dose-rate irradiation reveal a DNA DSB rejoining defect in cells from human ATM heterozygotes in two AT families and in another apparently normal individual. Radiat. Res. 166, 443-453 (2006).
65. T. A. Kato, P. F. Wilson, H. Nagasawa, M. M. Fitzek, M. M. Weil, J. B. Little and J. S. Bedford, A defect in DNA double-strand break processing in cells from unaffected parents of retinoblastoma patients and other apparently normal humans. DNA Repair 6, 818-829 (2007).
66. D. E. Weeks, M. C. Paterson, K. Lange, B. Andrais, R. C. Davis, F. Yoder and R. A. Gatti, Assessment of chronic γ radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat. Res. 128, 90-99 (1991).
67. S. A. G. Elyan, C. M. L. West, S. A. Roberts and R. D. Hunter, Use of low dose-rate irradiation to measure the intrinsic radiosensitivity of human T-lymphocytes. Int. J. Radiat. Biol. 64, 375-383 (1993).
68. J. B. Mitchell, J. S. Bedford and S. M. Bailey, Dose-rate effects in plateau-phase cultures of S3 HeLa and V79 cells. Radiat. Res. 79, 552-567 (1979).
69. R. L. Wells and J. S. Bedford, Dose-rate effects in mammalian cells. IV. Repairable and non-repairable damage in noncycling C3H 10T1/2cells. Radiat. Res. 94, 105-134 (1983).
70. J. S. Bedford, Sublethal damage, potentially lethal damage and chromosomal aberrations in mammalian cells exposed to ionizing radiations. Int. J. Radiat. Oncol. Biol. Phys. 21, 1457-1469 (1991).
71. K. Rothkamm, I. Krüger, L. H. Thompson and M. Löbrich, Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell. Biol. 23, 5706-5715 (2003).
72. L. H. Thompson and C. L. Limoli, Origin, recognition, signaling, and repair of DNA double strand breaks in mammalian cells. In Eukaryotic DNA Damage Surveillance and Repair (K. W. Caldecott, Ed.), pp. 107-145. Kluwer Academic/Plenum Publishers, New York, 2003.
73. K. Valerie and L. F. Povirk, Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22, 5792-5812 (2003).
74. H. E. Johns and J. R. Cunningham, The Physics of Radiology, 4th ed. Charles C. Thomas, Springfield, IL, 1983.
75. J. W. Boag, The statistical treatment of cell survival data. In Cell Survival after Low Doses of Radiation: Theoretical and Clinical Implications (T. Alper, Ed.), 40-53. Wiley, London, 1975.
76. R. E. Tarone, D. A. Scudiero and J. H. Robbins, Statistical methods for in vitro cell survival assays. Mutat. Res. 111, 79-96 (1983).
77. B. Fertil and P. J. Deschavanne, Relationships between colony forming efficiency and parameters of intrinsic radiosensitivity. Int. J. Radiat. Biol. 75, 1275-1282 (1999).
78. J. S. Bedford, J. B. Mitchell and M. H. Fox, Variations in responses of several mammalian cell lines to low dose-rate irradiation. In Radiation Biology in Cancer Research (R. E. Meyn and H. R. Withers, Eds.), pp. 251-262. Elsevier, Amsterdam, 1980.
79. T. Lindahl, Instability and decay of the primary structure of DNA. Nature 362, 709-715 (1993).
80. J. F. Ward, Nature of lesions formed by ionizing radiation. In DNA Damage and Repair, Volume II: DNA Repair in Higher Eukaryotes (J. A. Nickoloff and M. F. Hoekstra, Eds.), pp. 65-84. Springer, Berlin, 1998.
81. M. M. Vilenchik and A. G. Knudson, Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer. Proc. Natl. Acad. Sci. USA 100, 12871-12876 (2003).
82. B. M. Sutherland, P. V. Bennett, J. C. Sutherland and J. Laval, Clustered DNA damages induced by X rays in human cells. Radiat. Res. 157, 611-616 (2002).
83. M. Gulston, C. de Lara, T. Jenner, E. Davis and P. O'Neill, Processing of clustered DNA damage generates additional double-strand breaks in mammalian cells post-irradiation. Nucleic Acids Res. 32, 1602-1609 (2004).
84. D. T. Goodhead, Track structure considerations in low dose and low dose rate effects of ionizing radiation. Adv. Radiat. Biol. 16, 7-44 (1992).
85. K. Rothkamm and M. Löbrich, Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. USA 100, 5057-5062 (2003).
86. S. J. Collis, J. M. Schwaninger, A. J. Ntambi, T. W. Keller, W. G. Nelson, L. E. Dillehay and T. L. De Weese, Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J. Biol. Chem. 279, 49624-49632 (2004).
87. K. Ishizaki, Y. Hayashi, H. Nakamura, Y. Yasui, K. Komatsu and A. Tachibana, No induction of p53 phosphorylation and few focus formation of phosphorylated H2AX suggest efficient repair of DNA damage during chronic low dose-rate irradiation in human cells. J. Radiat. Res. 45, 521-525 (2004).
88. T. Sugihara, J. Magae, R. Wadhwa, S. C. Kaul, Y. Kawakami, T. Matsumoto and K. Tanaka, Dose and dose-rate effects of low-dose ionizing radiation on the activation of trp53 in immortalized murine cells. Radiat. Res. 162, 296-307 (2004).
89. E. Dikomey, J. Dahm-Daphi, I. Brammer, R. Martensen and B. Kaina, Correlation between cellular radiosensitivity and non-repaired double-strand breaks studied in nine mammalian cell lines. Int. J. Radiat. Biol. 73, 269-278 (1998).
90. E. Dikomey and I. Brammer, Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal human fibroblast line. Int. J. Radiat. Biol. 76, 773-781 (2000).
91. K. K. Khanna and S. P. Jackson, DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247-254 (2001).
92. D. C. van Gent, J. H. Hoeijmakers and R. Kanaar, Chromosomal stability and the double-stranded break connection. Nat. Rev. Genet. 2, 196-206 (2001).
93. M. M. Vilenchik and A. G. Knudson, Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc. Natl. Acad. Sci. USA 97, 5381-5386 (2000).
94. M. M. Vilenchik and A. G. Knudson, Radiation dose-rate effects, endogenous DNA damage and signaling resonance. Proc. Natl. Acad. Sci. USA 103, 17874-17879 (2006).
95. C-Y. Li, H. Nagasawa, W. K. Dahlberg and J. B. Little, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11, 1885-1892 (1995).